Daniela Traini

Cited by

	All	Since 2019
Citations	9500	5144
h-index	54	34
i10-index	209	154

1100

550

275

825

20072008200920102011201220132014201520162017201820192020202120222023202453 68 129 157 258 304 370 470 636 638 466 708 736 747 1001 1010 849 784

Public access

View all

65 articles

43 articles

available

not available

Based on funding mandates

Co-authors

Paul M YoungUniversity of SydneyVerified email at sydney.edu.au
Ong Hui XinRespiratory Technology, Woolcock Institute of Medical ResearchVerified email at mq.edu.au
hakkim chanProfessor in Pharmaceutics, University of SydneyVerified email at sydney.edu.au
Wing Hin LeeFaculty of Pharmacy & Health Sciences, Royal College of Medicine Perak, Universiti of Kuala LumpurVerified email at unikl.edu.my
Mehra HaghiSchool of Pharmacy, Graduate School of Health, University of Technology, SydneyVerified email at uts.edu.au
Ching Yee LooFaculty of Pharmacy & Health Sciences, Royal College of Medicine Perak, Universiti of Kuala LumpurVerified email at unikl.edu.my
Maliheh GhadiriAnn Woolcock Fellow, Woolcock Institute of Medical ResearchVerified email at sydney.edu.au
David F. FletcherUniversity of SydneyVerified email at sydney.edu.au
Paolo ColomboDepartment of Pharmacy, University of Parma, ItalyVerified email at unipr.it
Prof. Robert PriceProfessor of PharmaceuticsVerified email at bath.ac.uk
Herbert ChiouUniversity of Sydney, 3M, Lupin, Lonza, Moderna, Generation BioVerified email at mmm.com
Associate Professor Fabio SonvicoUniversity of ParmaVerified email at unipr.it
Matthew D JonesUniversity of BathVerified email at bath.ac.uk
Gaia ColomboUniversità di FerraraVerified email at unife.it
Daniel J. DukeMonash UniversityVerified email at monash.edu
Daniel Edgington-MitchellAssociate Professor, Monash UniversityVerified email at eng.monash.edu.au
Sumit AroraSenior Principal Scientist Biopharmaceutics Janssen PharmaceuticaVerified email at its.jnj.com
Sanyog JainCentre for Pharmaceutical Nanotechnology, Dept of Pharmaceutics, NIPERVerified email at niper.ac.in
Warwick BrittonProfessor of Medicine, University of Sydney and Centenary InstituteVerified email at centenary.org.au
Edward James LongSenior Research Associate at Loughborough UniversityVerified email at lboro.ac.uk

Daniela Traini

University of Sydney

Verified email at sydney.edu.au - Homepage

Aerosol Drug Delivery to the Lung


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Recent advances in curcumin nanoformulation for cancer therapy WH Lee, CY Loo, PM Young, D Traini, RS Mason, R Rohanizadeh Expert opinion on drug delivery 11 (8), 1183-1201, 2014	265	2014
Strategies to enhance drug absorption via nasal and pulmonary routes M Ghadiri, PM Young, D Traini Pharmaceutics 11 (3), 113, 2019	212	2019
Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges WH Lee, CY Loo, D Traini, PM Young Asian journal of pharmaceutical sciences 10 (6), 481-489, 2015	200	2015
Combination of silver nanoparticles and curcumin nanoparticles for enhanced anti-biofilm activities CY Loo, R Rohanizadeh, PM Young, D Traini, R Cavaliere, ... Journal of agricultural and food chemistry 64 (12), 2513-2522, 2016	188	2016
Nano-and micro-based inhaled drug delivery systems for targeting alveolar macrophages WH Lee, CY Loo, D Traini, PM Young Expert opinion on drug delivery 12 (6), 1009-1026, 2015	177	2015
Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems PM Young, A Sung, D Traini, P Kwok, H Chiou, HK Chan Pharmaceutical research 24, 963-970, 2007	160	2007
The influence of dose on the performance of dry powder inhalation systems PM Young, S Edge, D Traini, MD Jones, R Price, D El-Sabawi, C Urry, ... International journal of pharmaceutics 296 (1-2), 26-33, 2005	148	2005
Time-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model M Haghi, PM Young, D Traini, R Jaiswal, J Gong, M Bebawy Drug development and industrial pharmacy 36 (10), 1207-1214, 2010	143	2010
The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects PGA Rogueda, D Traini Expert opinion on drug delivery 4 (6), 595-606, 2007	133	2007
Co-spray-dried mannitol–ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease H Adi, PM Young, HK Chan, H Agus, D Traini European Journal of Pharmaceutical Sciences 40 (3), 239-247, 2010	131	2010
The influence of lactose pseudopolymorphic form on salbutamol sulfate–lactose interactions in DPI formulations D Traini, PM Young, F Thielmann, M Acharya Drug development and industrial pharmacy 34 (9), 992-1001, 2008	127	2008
Preparation and characterisation of controlled release co-spray dried drug–polymer microparticles for inhalation 2: Evaluation of in vitro release profiling methodologies for … RO Salama, D Traini, HK Chan, PM Young European Journal of Pharmaceutics and Biopharmaceutics 70 (1), 145-152, 2008	116	2008
Delivery of antibiotics to the respiratory tract: an update D Traini, PM Young Expert opinion on drug delivery 6 (9), 897-905, 2009	113	2009
Solid lipid microparticles as an approach to drug delivery S Scalia, PM Young, D Traini Expert opinion on drug delivery 12 (4), 583-599, 2015	112	2015
The use of computational approaches in inhaler development W Wong, DF Fletcher, D Traini, HK Chan, PM Young Advanced drug delivery reviews 64 (4), 312-322, 2012	110	2012
The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations H Adi, D Traini, HK Chan, PM Young Journal of pharmaceutical sciences 97 (7), 2780-2788, 2008	110	2008
Micro-particle corrugation, adhesion and inhalation aerosol efficiency S Adi, H Adi, P Tang, D Traini, H Chan, PM Young European Journal of Pharmaceutical Sciences 35 (1-2), 12-18, 2008	109	2008
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics JGY Chan, HK Chan, CA Prestidge, JA Denman, PM Young, D Traini European Journal of Pharmaceutics and Biopharmaceutics 83 (2), 285-292, 2013	107	2013
Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation H Adi, I Larson, H Chiou, P Young, D Traini, P Stewart Pharmaceutical research 23, 2556-2565, 2006	102	2006
Pharmaceutical applications of the Calu-3 lung epithelia cell line HX Ong, D Traini, PM Young Expert opinion on drug delivery 10 (9), 1287-1302, 2013	98	2013

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors